153 related articles for article (PubMed ID: 37542163)
1. What role for somatic mutations in systemic inflammatory and autoimmune diseases associated with myelodysplastic neoplasms and chronic myelomonocytic leukemias?
Zhao LP; Fenaux P
Leukemia; 2023 Sep; 37(9):1943. PubMed ID: 37542163
[No Abstract] [Full Text] [Related]
2. What role for somatic mutations in systemic inflammatory and autoimmune diseases associated with myelodysplastic neoplasms and chronic myelomonocytic leukemias?
Zhao LP; Sébert M; Mékinian A; Fain O; Espéli M; Balabanian K; Dulphy N; Adès L; Fenaux P
Leukemia; 2023 Jun; 37(6):1186-1190. PubMed ID: 37024519
[No Abstract] [Full Text] [Related]
3. Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease.
Zhao LP; Boy M; Azoulay C; Clappier E; Sébert M; Amable L; Klibi J; Benlagha K; Espéli M; Balabanian K; Preudhomme C; Marceau-Renaut A; Benajiba L; Itzykson R; Mekinian A; Fain O; Toubert A; Fenaux P; Dulphy N; Adès L
Leukemia; 2021 Sep; 35(9):2720-2724. PubMed ID: 33623140
[No Abstract] [Full Text] [Related]
4. Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune disease.
Zhao LP; Schell B; Sébert M; Kim R; Lemaire P; Boy M; Mathis S; Larcher L; Chauvel C; Dhouaieb MB; Bisio V; Preudhomme C; Marceau-Renaut A; Itzykson R; Mekinian A; Fain O; Toubert A; Fenaux P; Dulphy N; Clappier E; Adès L
Leukemia; 2021 Sep; 35(9):2731-2733. PubMed ID: 34344988
[No Abstract] [Full Text] [Related]
5. Looking for somatic mutations in
Dupuy H; Dussiau C; Bidet A; Sauvezie M; De-Grande AC; Decombe J; Rivière É; Forcade E; Bonnet F; Dumas PY; Duffau P; Pigneux A; Viallard JF; Lazaro E; Dimicoli-Salazar S
Leuk Lymphoma; 2022 Jan; 63(1):250-252. PubMed ID: 34474632
[No Abstract] [Full Text] [Related]
6. Increased cardiovascular comorbidities in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia presenting with systemic inflammatory and autoimmune manifestations.
Kipfer B; Daikeler T; Kuchen S; Hallal M; Andina N; Allam R; Bonadies N
Semin Hematol; 2018 Oct; 55(4):242-247. PubMed ID: 30502853
[TBL] [Abstract][Full Text] [Related]
7. [Dysimmune manifestations associated with myelodysplastic neoplasms and chronic myelomonocytic leukaemias].
Jachiet V; Hadjadj J; Zhao LP; Chasset F; Fain O; Fenaux P; Mekinian A
Bull Cancer; 2023 Nov; 110(11):1147-1155. PubMed ID: 37414632
[TBL] [Abstract][Full Text] [Related]
8. Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts.
Gelsi-Boyer V; Cervera N; Bertucci F; Brecqueville M; Finetti P; Murati A; Arnoulet C; Mozziconacci MJ; Mills KI; Cross NC; Vey N; Birnbaum D
Haematologica; 2013 Apr; 98(4):576-83. PubMed ID: 23065512
[TBL] [Abstract][Full Text] [Related]
9. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.
Damm F; Itzykson R; Kosmider O; Droin N; Renneville A; Chesnais V; Gelsi-Boyer V; de Botton S; Vey N; Preudhomme C; Clavert A; Delabesse E; Park S; Birnbaum D; Fontenay M; Bernard OA; Solary E
Leukemia; 2013 Jun; 27(6):1401-3. PubMed ID: 23443343
[No Abstract] [Full Text] [Related]
10. Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study.
Péan de Ponfilly-Sotier M; Jachiet V; Benhamou Y; Lahuna C; De Renzis B; Kottler D; Voillat L; Dimicoli-Salazar S; Banos A; Chauveheid MP; Alexandra JF; Grignano E; Liferman F; Laborde M; Broner J; Michel M; Lambotte O; Laribi K; Venon MD; Dussol B; Martis N; Thepot S; Park S; Couret D; Roux-Sauvat M; Terriou L; Hachulla E; Bally C; Galland J; Allain JS; Parcelier A; Peterlin P; Cohen-Bittan J; Regent A; Ackermann F; Le Guen J; Algrin C; Charles P; Daguindau E; Puechal X; Dunogue B; Blanchard-Delaunay C; Beyne-Rauzy O; Grobost V; Schmidt J; Le Gallou T; Dubos-Lascu G; Sonet A; Denis G; Roy-Peaud F; Fenaux P; Adès L; Fain O; Mekinian A;
Clin Exp Rheumatol; 2022 Jul; 40(7):1336-1342. PubMed ID: 35579092
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome.
Isoda A; Sakurai A; Ogawa Y; Miyazawa Y; Saito A; Matsumoto M; Sawamura M
Int J Hematol; 2009 Sep; 90(2):239-242. PubMed ID: 19588217
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Saif MW; Hopkins JL; Gore SD
Leuk Lymphoma; 2002 Nov; 43(11):2083-92. PubMed ID: 12533032
[TBL] [Abstract][Full Text] [Related]
13. Systemic vasculitis in myelodysplastic syndromes.
Oostvogels R; Petersen EJ; Chauffaille ML; Abrahams AC
Neth J Med; 2012 Mar; 70(2):63-8. PubMed ID: 22418751
[TBL] [Abstract][Full Text] [Related]
14. Mutated
Valencia-Martinez A; Sanna A; Masala E; Contini E; Brogi A; Gozzini A; Santini V
Haematologica; 2017 Sep; 102(9):e332-e335. PubMed ID: 28522578
[No Abstract] [Full Text] [Related]
15. Spectrum of autoimmune diseases and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemia.
Zahid MF; Barraco D; Lasho TL; Finke C; Ketterling RP; Gangat N; Hanson CA; Tefferi A; Patnaik MM
Leuk Lymphoma; 2017 Jun; 58(6):1488-1493. PubMed ID: 27739921
[No Abstract] [Full Text] [Related]
16. Behçet disease associated with myelodysplastic syndrome.
Lin YC; Liang TH; Chang HN; Lin JS; Lin HY
J Clin Rheumatol; 2008 Jun; 14(3):169-74. PubMed ID: 18525438
[TBL] [Abstract][Full Text] [Related]
17. A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML.
Mekinian A; Zhao LP; Chevret S; Desseaux K; Pascal L; Comont T; Maria A; Peterlin P; Terriou L; D'Aveni Piney M; Gourin MP; Vey N; Rauzy OB; Grobost V; Bezanahary H; Dimicoli-Salazar S; Banos A; Wickenhauser S; De Renzis B; Durot E; Natarajan-Amé S; Voillat L; Chermat F; Lemaire K; Jachiet V; Himberlin C; Thépot S; Diaz JMT; Frenzel L; Gyan E; Denis G; Hirsch P; Kosmider O; Ades L; Fain O; Fenaux P
Leukemia; 2022 Nov; 36(11):2739-2742. PubMed ID: 36104395
[No Abstract] [Full Text] [Related]
18. ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia.
Padron E; Yoder S; Kunigal S; Mesa T; Teer JK; Al Ali N; Sekeres MA; Painter JS; Zhang L; Lancet J; Maciejewski JP; Epling-Burnette PK; Sotomayor E; Komrokji RS; List AF
Blood; 2014 Jun; 123(23):3675-7. PubMed ID: 24904105
[No Abstract] [Full Text] [Related]
19. Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series.
Martin de Frémont G; Hirsch P; Gimenez de Mestral S; Moguelet P; Ditchi Y; Emile JF; Senet P; Georgin-Lavialle S; Hanslik T; Maurier F; Adedjouma A; Abisror N; Mahevas T; Malard F; Adès L; Fenaux P; Fain O; Chasset F; Mekinian A
Front Immunol; 2021; 12():715053. PubMed ID: 34671345
[TBL] [Abstract][Full Text] [Related]
20. Myelodysplasia cutis as the presenting sign of chronic myelomonocytic leukaemia.
Maglie R; Senatore S; Di Stefano G; Barzacchi M; Maio V; Montefusco F; Baffa ME; Bianchi B; Santucci M; Antiga E
Clin Exp Dermatol; 2022 Apr; 47(4):773-775. PubMed ID: 34888907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
